4D Molecular Therapeutics Inc. (FDMT) Social Stream

Featured Post From StockTwits About FDMT

$FDMT New SEC Filing: 8-K Earnings - 4D Molecular Therapeutics Inc. (0001650648) August 12


Item 2.02 Results of Operations and Financial Condition. On August 12, 2021, 4D Molecular Therapeutics, Inc. ("4DMT") announced its unaudited financial results for the quarter ended June 30, 2021. A copy of 4DMT's press release, titled "4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights," is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated August 12, 2021 titled "4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights" 104 Cover Page Interactive (...)

https://mkn.re/96382